Elekta announced today that it entered into a joint venture with Sinopharm to increase the adoption of radiation therapy in China. The initiative aims to bring radiation therapy to what’s considered lower-tier cities. These cities comprise approximately 70% of China’s population, according to a news release. Elekta develops precision radiation therapy to treat cancer. The […]
Elekta
FDA clears Elekta’s radiation therapy automation
Elekta (Stockholm:EKTA-B) says an FDA 510(k) clearance represents a new era in precision radiation therapy to treat cancer in the U.S. The Sweden-based cancer and brain treatment tech company announced today that the FDA has cleared Comprehensive Motion Management (CMM) with True Tracking and automatic gating. The features are part of Elekta’s Unity MR-Linac radiotherapy […]
Elekta launches its Elekta Esprit radiosurgery system
Elekta (KTA-B.ST) announced today that it launched its Espirit automated treatment planning system. Stockholm, Sweden-based Elekta designed its latest and most advanced system to offer significantly faster, automated treatment planning for clinicians, with more personalized and patient-friendly treatments and a degree of precision capable of protecting the mind and the person. The company said in […]
GE Healthcare, Elekta collaborate to expand precision radiation therapy access
GE Healthcare (NYSE:GE) and Elekta (EKTA-B.ST) recently announced that they have inked a global commercial collaboration agreement. The partnership covers the radiation oncology field. It’s meant to enable the two companies to provide hospitals a comprehensive offering across imaging and treatment for cancer patients. “Access to radiation therapy is a significant challenge in several parts […]
Elekta names permanent CFO
Elekta (STO:EKTA B) today said it has appointed Johan Adebäck as chief financial officer, effective immediately. Adebäck has served as the acting chief financial officer since June of last year. He was previously the group treasurer of the company since 2004, where he was responsible for treasury, taxes, customer financing, operations accounting and customer credit risk. […]
Elekta wins FDA approval for diffusion-weighted images
Elekta (STO:EKTA B) today announced that it received FDA 510(k) premarket notification for its diffusion-weighted MR images from the Elekta Unity. The clearance allows the images to be interpreted by a trained physician. With the new FDA clearance, the system can be used for the biologic assessment of tumor response during therapy. Diffusion-weighted MR images (DWI) […]
Elekta buys treatment planner ProKnow Systems
Elekta (STO:EKTA B) said today that it acquired ProKnow Systems for an undisclosed amount in a move toward cloud-based solutions for advanced radiation therapy. Sweden-based Elekta will have access to ProKnow’s products, namely the ProKnow DS, to offer the cloud-based analytics systems and standardize its practices. The ProKnow DS is designed to allow for analysis of […]
Elekta files patent suit against Zap Surgical
Surgical system maker Zap Surgical Systems said yesterday that it is facing a patent infringement lawsuit from Elekta (STO:EKTA B) related to its Zap-X gyroscopic radiosurgery platform. San Carlos, Calif.-based Zap Surgical said that said that it is facing a lawsuit in the U.S. District Court for the Northern District of California asserting that its Zap-X […]
Elekta wins Health Canada approval for Elekta Unity MR radiation therapy system
Elekta (STO:EKTA B) said today that it won Health Canada approval for its Elekta Unity magnetic resonance radiation therapy system. The Elekta Unity system consists of a high-field 1.5 Tesla MRI scanner and a linear accelerator alongside integrated real-time dose planning software for target monitoring, the Stockholm-based company said. Elekta added that its Elekta Unity device […]
Elekta picks up radiology QA software dev Acumyn
Elekta (STO:EKTA B) said late last week it acquired Canadian quality assurance company Acumyn for an undisclosed amount. Acumyn, which spun-out of Toronto’s University Hospital Network, was started to commercialize the Aqua software platform. Aqua is intended to coordinate, centralize and automate all QA tests that need to be performed in radiotherapy clinics, Elekta said. “This […]
York Instruments picks up Elekta’s MEG biz
Croton Healthcare subsidiary York Instruments said today that it’s buying the magnetoencephalography business at Elekta (STO:EKTA B) for an undisclosed amount. The MEG technology is designed to map brain activity in clinical and research settings. Elekta’s MEGIN business put up sales of about $11.6 million last year (SEK102 million). Get the full story at our sister site, Medical […]
